HIV Clinical Trial
— LatinoSTYLEOfficial title:
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Verified date | September 2016 |
Source | University of South Florida |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The proposed project will test an HIV prevention intervention for Latino parent-adolescents
dyads. This randomized controlled trial will:
1. Recruit and randomize 320 parent-adolescent dyads into a Latino family-based HIV
prevention intervention or a family-based General Health Promotion condition.
2. Determine the efficacy of the Latino Family-based HIV prevention intervention from
assessment of changes in HIV-related sexual behavior and attitudes over 18 months among
a sample of 320 Latino parent-adolescent dyads.
3. Determine the efficacy of the Latino Family-based HIV prevention intervention from
assessment of changes in family relationships and parental monitoring/supervision over
18 months among a sample of 320 Latino parent-adolescent dyads.
4. Examine the association of other important constructs, such as religiosity,
acculturation, cultural values, and sexual socialization with the primary outcomes.
Based on a thorough review of the literature and preliminary data from a recent, small pilot
study, the investigators hypotheses are:
1. Compared to the General Health Promotion Control condition, the Family-Based HIV
Prevention intervention will result in greater change with regard to primary outcome
measures of safer sexual behavior (recent sexual activity, the number of unprotected
sex acts, and intentions to use condoms) and safer HIV-related attitudes.
2. Compared to the General Health Promotion Control condition, the Family-Based HIV
Prevention intervention will result in greater change with regard to family
relationships and parental monitoring/supervision through improved parent-child
communication skills and they will mediate the intervention impact.
3. Religiosity, acculturation, cultural values, and sexual socialization will have
meaningful associations with the primary outcomes and will act as moderators of
intervention impact.
Status | Completed |
Enrollment | 542 |
Est. completion date | September 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 14 Years and older |
Eligibility |
Inclusion Criteria: - Adolescents and parents self-identify as Latino/Hispanic - Adolescents between the ages of 14 and 17 - Parent is Spanish-Speaking and feels comfortable speaking Spanish in groups - Adolescent is English-speaking and feels comfortable speaking English in groups - Adolescent meets behavioral inclusion criteria (not disclosed) Exclusion Criteria: - Adolescent self-discloses HIV positive status - Currently or intending to be pregnant during the course of the study |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | University of South Florida | Tampa | Florida |
Lead Sponsor | Collaborator |
---|---|
University of South Florida | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in sexual activity status | baseline and 3, 6, 12, and 18 months post-intervention | No | |
Secondary | Change in Unprotected Sex Acts | change in the number of incidences of unprotected vaginal or anal intercourse | baseline and 3, 6, 12, and 18 months post-intervention | No |
Secondary | Change in intentions to use condoms | baseline and 3, 6, 12, and 18 months post-intervention | No | |
Secondary | Change in parent-adolescent communication | baseline and 3, 6, 12, and 18 months post-intervention | No | |
Secondary | change in parental monitoring of adolescent | baseline and 3, 6, 12, and 18 months post-intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |